At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 14 enrolled
Drug / intervention
Agiocur Pregranulesdrug
Likely dose
Agiocur Pregranules 6gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus
In Brief
A Phase 4 clinical trial evaluating Agiocur Pregranules for Diabetes Mellitus, Type 2. Completed, enrolled 14 participants.
Detailed Summary
The purpose of this study is to determine the effect of a commercial dietary fiber supplement on patients with type 2 diabetes mellitus, in the way of glucose control, insulin action in the body, and the gut microbiota (bacteria) abundance.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
Countries--
CollaboratorsBukwang Pharmaceutical, Co., Ltd., ChunLab, Inc.
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2014
Primary CompletionOct 2015
Study CompletionMay 2018
First PostedJun 2018
TodayJul 2026
First PostedJun 12, 2018
Enrollment StartFeb 1, 2014
Primary CompletionOct 1, 2015
Study CompletionMay 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.1 years ago
Interventions
Agiocur Pregranulesdrug
6g before breakfast and 12g after dinner for first 28 days, and no medication for next 28 days for washout